SCHEMBL29133765

SCHEMBL29133765

Cc1ncc(-c2ccc3ncnc(NCCc4ccccc4)c3c2)cc1N(S(C)(=O)=O)S(C)(=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.54
PIK3CA P42336 3/20 0.51
DYRK1A Q13627 1/20 0.49
CCNC P24863 1/20 0.48
CDKN1A P38936 1/20 0.48
CDK8 P49336 1/20 0.48
CDK19 Q9BWU1 1/20 0.48
MAPK1 P28482 9/20 0.48
LMNA P02545 7/20 0.48
APP P05067 1/20 0.48
HTT P42858 1/20 0.48
CYP1A2 P05177 8/20 0.47
CYP3A4 P08684 8/20 0.47
ALDH1A1 P00352 7/20 0.47
CYP2D6 P10635 7/20 0.47
CYP2C19 P33261 7/20 0.47
HSD17B10 Q99714 6/20 0.47
HIF1A Q16665 5/20 0.47
KDM4E B2RXH2 4/20 0.47
HPGD P15428 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133751 0.85 EGFR (0.68) EGFRPIK3CADYRK1ACCNCCDKN1A
SCHEMBL29133715 0.84 EGFR (0.59) EGFRPIK3CADYRK1ACCNCCDKN1A
SCHEMBL29133712 0.82 MAPK1 (0.55) EGFRPIK3CADYRK1ACCNCCDKN1A
SCHEMBL24609363 0.81 EGFR (0.64) EGFRPIK3CADYRK1ALMNACYP1A2
Formamide SCHEMBL29133744 0.80 MAPK1 (0.51) EGFRPIK3CADYRK1ACCNCCDKN1A
SCHEMBL27170398 0.79 EGFR (0.84) EGFRPIK3CADYRK1ACCNCCDKN1A
SCHEMBL29133708 0.78 EGFR (0.82) EGFRPIK3CADYRK1ACCNCCDKN1A
SCHEMBL29133777 0.78 PIK3CA (0.75) EGFRPIK3CALMNACYP1A2CYP3A4
SCHEMBL29133726 0.76 MAPK1 (0.61) EGFRDYRK1ACCNCCDKN1ACDK8
SCHEMBL4173540 0.75 IRAK4 (0.49) EGFRPIK3CADYRK1ACCNCCDKN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed